These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 427592)

  • 21. Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity.
    Feigenbaum J; Yanai J; Klawans H; Moon B
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):349-52. PubMed ID: 6844751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in noradrenergic terminal excitability induced by amphetamine and their relation to impulse traffic.
    Nakamura S; Tepper JM; Young SJ; Groves PM
    Neuroscience; 1982; 7(9):2217-24. PubMed ID: 6292781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphetamine's effects on terminal excitability of noradrenergic locus coeruleus neurons are impulse-dependent at low but not high doses.
    Ryan LJ; Tepper JM; Young SJ; Groves PM
    Brain Res; 1985 Aug; 341(1):155-63. PubMed ID: 4041784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuroanatomy and pharmacology of the nucleus locus coeruleus.
    Grant SJ; Redmond DE
    Prog Clin Biol Res; 1981; 71():5-27. PubMed ID: 6276901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desipramine-induced increase in efflux of endogenous dopamine from rat hypothalamus in vitro: mechanism and specificity.
    Myers SL; Tessel RE
    Neuropharmacology; 1983 May; 22(5):601-7. PubMed ID: 6877537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain.
    Bareggi SR; Markey K; Genovese E
    Eur J Pharmacol; 1978 Aug; 50(4):301-6. PubMed ID: 699958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible relationship of the locus coeruleus--hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs.
    Kostowski W
    Pol J Pharmacol Pharm; 1985; 37(6):727-43. PubMed ID: 3008134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine.
    Ramirez OA; Wang RY
    Brain Res; 1986 Jan; 362(1):165-70. PubMed ID: 2867813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity.
    Akaoka H; Roussel B; Lin JS; Chouvet G; Jouvet M
    Neurosci Lett; 1991 Feb; 123(1):20-2. PubMed ID: 1676498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilocarpine-induced convulsions in rats: evidence for muscarinic receptor-mediated activation of locus coeruleus and norepinephrine release in cholinolytic seizure development.
    el-Etri MM; Ennis M; Jiang M; Shipley MT
    Exp Neurol; 1993 May; 121(1):24-39. PubMed ID: 7684335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine.
    Svensson TH; Bunney BS; Aghajanian GK
    Brain Res; 1975 Jul; 92(2):291-306. PubMed ID: 1174954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat.
    Ortega JE; Mendiguren A; Pineda J; Meana JJ
    Neuropharmacology; 2012 Jun; 62(8):2472-9. PubMed ID: 22401957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
    Cooper BR; Wang CM; Cox RF; Norton R; Shea V; Ferris RM
    Neuropsychopharmacology; 1994 Oct; 11(2):133-41. PubMed ID: 7840865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits.
    Eisenhofer G; Saigusa T; Esler MD; Cox HS; Angus JA; Dorward PK
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R824-32. PubMed ID: 1672797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
    Pan WH; Yang SY; Lin SK
    Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons.
    Souto M; Monti JM; Altier H
    Pharmacol Biochem Behav; 1979 Jan; 10(1):5-9. PubMed ID: 441095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons.
    Tian Y; Lookingland KJ; Moore KE
    Brain Res; 1991 Jul; 555(1):135-40. PubMed ID: 1681993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of desipramine on norepinephrine metabolism in humans: interaction with aging.
    Stromberg JS; Linares OA; Supiano MA; Smith MJ; Foster AH; Halter JB
    Am J Physiol; 1991 Dec; 261(6 Pt 2):R1484-90. PubMed ID: 1750571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.
    Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo.
    Heidbreder CA; Bianchi M; Lacroix LP; Faedo S; Perdona E; Remelli R; Cavanni P; Crespi F
    Synapse; 2003 Dec; 50(4):269-76. PubMed ID: 14556231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.